MedTrace Logo

Finding Immune Nascent Type 1 Diabetes

NCT07663136 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3800

Last updated 2026-06-23

No results posted yet for this study

Summary

The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon different methods of recruitment communication. The main question it aims to answer is:

What form of recruitment communication is most effective for completing a type 1diabetes home screening kit?

Researchers will compare two types of recruitment contact: email and mail based communication (low-touch) versus phone contact and follow-up by a research team member (high-touch).

Participants will be contacted either via email/mail or by phone and asked if they want to complete a type 1 diabetes home screening kit.

Conditions

  • Healthy Adult
  • Type 1 Diabetes (T1D)

Interventions

BEHAVIORAL

phone call

Recruitment through phone call

BEHAVIORAL

email/mail

Recruitment through email and mail

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY

  • Indiana University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2029-06-30
Completion
2029-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07663136 on ClinicalTrials.gov